TY - JOUR
T1 - Patient Characteristics and Concerns about Drug Allergy
T2 - A Report from the United States Drug Allergy Registry
AU - USDAR Study Team
AU - Blumenthal, Kimberly G.
AU - Harkness, Tyler
AU - Phillips, Elizabeth J.
AU - Ramsey, Allison
AU - Banerji, Aleena
AU - Samarakoon, Upeka
AU - Stone, Cosby
AU - Fu, Xiaoqing
AU - Khan, David A.
AU - Otani, Iris
AU - Camargo, Carlos A.
AU - Zhang, Yuqing
AU - Donelan, Karen
AU - Mancini, Christian M.
AU - Ahola, Catherine M.
AU - Judd, Allen D.
AU - Arman, Weaam
AU - Phillips, Elizabeth
AU - Williams, Kristina
AU - Osea, Ronald Eugene
AU - Mustafa, S. Shahzad
AU - Blue, Holly
AU - Guyer, Autumn
AU - Khan, David
N1 - Funding Information:
This work was supported by the American Academy of Allergy Asthma and Immunology Foundation and the Massachusetts General Hospital’s Claflin Distinguished Scholars Award and Corinne A. Basler Transformative Scholar in Medicine.
Funding Information:
Conflicts of interest: C. Stone receives K-12 funding from the Agency for Healthcare Research and Quality / Patient-Centered Outcome Research Institute for research in risk-stratified management of penicillin allergy. The rest of the authors declare that they have no relevant conflicts of interest.
Publisher Copyright:
© 2020 American Academy of Allergy, Asthma & Immunology
PY - 2020/10
Y1 - 2020/10
N2 - Background: Drug allergy is frequently reported, but uncommonly confirmed with diagnostic testing. Although drug allergy assessments can improve clinical care, patient concerns may impact the optimal diagnostic approach and/or the clinical effectiveness of diagnostic testing. Objective: To assess drug allergy patient concerns. Methods: Using data from a multisite, prospective longitudinal cohort study, the United States Drug Allergy Registry (January 16, 2019, to January 24, 2020), we determined patient self-reported characteristics and qualitatively coded free-text patient concerns about their drug allergy/allergies. We assessed associations between patient characteristics and drug allergy concerns using multinomial logistic regression models. Results: Of 592 patients (mean age, 49 [standard deviation, 17] years, 74% female, 88% white), the most commonly reported drug allergies were penicillins (78%), cephalosporins (12%), and sulfonamides (12%) with common reactions of rash (62%), hives (54%), itching (48%), flushing or facial redness (28%), and swelling or angioedema (24%). Patient concerns, coded from free text, were optimal medication use (41%), no concern (17%), allergic reaction (14%), diagnosis (12%), and severe allergic reaction (12%). Using multinomial regression, the presence of drug allergy concerns increased with greater age, higher number of reported drug reactions, more antibiotic use, and certain reaction symptoms, most notably mouth or palate itching. Female sex was associated with increased severe allergic reaction concern. Poorer general and mental health was associated with increased allergic reaction concern. Conclusion: Patients with drug allergy were concerned about their options for medical treatment, having an allergic reaction, and receiving clarity about their diagnosis. Capturing and addressing patient concerns may improve the approach to patients with drug allergy and/or the effectiveness of drug allergy testing.
AB - Background: Drug allergy is frequently reported, but uncommonly confirmed with diagnostic testing. Although drug allergy assessments can improve clinical care, patient concerns may impact the optimal diagnostic approach and/or the clinical effectiveness of diagnostic testing. Objective: To assess drug allergy patient concerns. Methods: Using data from a multisite, prospective longitudinal cohort study, the United States Drug Allergy Registry (January 16, 2019, to January 24, 2020), we determined patient self-reported characteristics and qualitatively coded free-text patient concerns about their drug allergy/allergies. We assessed associations between patient characteristics and drug allergy concerns using multinomial logistic regression models. Results: Of 592 patients (mean age, 49 [standard deviation, 17] years, 74% female, 88% white), the most commonly reported drug allergies were penicillins (78%), cephalosporins (12%), and sulfonamides (12%) with common reactions of rash (62%), hives (54%), itching (48%), flushing or facial redness (28%), and swelling or angioedema (24%). Patient concerns, coded from free text, were optimal medication use (41%), no concern (17%), allergic reaction (14%), diagnosis (12%), and severe allergic reaction (12%). Using multinomial regression, the presence of drug allergy concerns increased with greater age, higher number of reported drug reactions, more antibiotic use, and certain reaction symptoms, most notably mouth or palate itching. Female sex was associated with increased severe allergic reaction concern. Poorer general and mental health was associated with increased allergic reaction concern. Conclusion: Patients with drug allergy were concerned about their options for medical treatment, having an allergic reaction, and receiving clarity about their diagnosis. Capturing and addressing patient concerns may improve the approach to patients with drug allergy and/or the effectiveness of drug allergy testing.
KW - Antibiotic
KW - Cephalosporin
KW - Drug challenge
KW - Hypersensitivity
KW - Immunologic
KW - Multiple drug hypersensitivity
KW - Multiple drug intolerance
KW - Penicillin
KW - Quality of life
KW - Skin test
UR - http://www.scopus.com/inward/record.url?scp=85091215343&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091215343&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2020.08.018
DO - 10.1016/j.jaip.2020.08.018
M3 - Article
C2 - 32853819
AN - SCOPUS:85091215343
SN - 2213-2198
VL - 8
SP - 2958
EP - 2967
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 9
ER -